Emmett Cunningham is listed as an executive officer and director on 6 SEC Form D filings by 5 issuers between Nov 2009 and May 2017: Clarus IV-D, L.P. (Cambridge, MA — pooled investment fund — 2017; $789.7M reported sold to 3 investors), Clarus IV-C, L.P. (Cambridge, MA — pooled investment fund — 2017; $789.7M reported sold to 26 investors), Clarus IV-B, L.P. (Cambridge, MA — pooled investment fund — 2017; $789.7M reported sold to 7 investors), Clarus IV-A, L.P. (Cambridge, MA — pooled investment fund — 2017; $789.7M reported sold to 30 investors) and SARcode Bioscience Inc. (Brisbane, CA — biotechnology — 2009; $43.6M reported sold to 9 investors).
What this means A repeat sponsor — 5 separate companies raised money with this person listed as executive officer and director, over about 8 years. Across those companies the filings report $3.2B sold in total.
4 of the issuers belong to the sponsor group Clarus (8 issuers, $3.53B reported sold, 2014–2017).
What this means A sponsor group is one team that sets up a new company for each deal. Clarus has 8 companies on file and $3.53B reported sold in total — the group page shows the whole track record in one place.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 6 public filings for Emmett Cunningham and found 5 differences: Offering amount changed between filings; 4 offerings have no amendment in the last 12 months and may still be open; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.